We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XHE icon
2976
State Street SPDR S&P Health Care Equipment ETF
XHE
$169M
$124K ﹤0.01%
+1,277
New +$121K
ZEUS
2977
DELISTED
Olympic Steel
ZEUS
$124K ﹤0.01%
10,945
+8,996
+462% +$99.7K
SREV
2978
DELISTED
ServiceSource International, Inc.
SREV
$124K ﹤0.01%
84,411
+70,335
+500% +$109K
ESXB
2979
DELISTED
Community Bankers Trust Corporation
ESXB
$124K ﹤0.01%
24,426
+10,229
+72% +$51.9K
BFH icon
2980
Bread Financial
BFH
$4.56B
$123K ﹤0.01%
3,669
-2,288
-38% -$81.3K
ESQ icon
2981
Esquire Financial Holdings
ESQ
$1.57B
$123K ﹤0.01%
8,198
+6,531
+392% +$104K
FTDR icon
2982
Frontdoor
FTDR
$5.94B
$123K ﹤0.01%
3,165
+3,001
+1,830% +$128K
LGND icon
2983
Ligand Pharmaceuticals
LGND
$5.84B
$123K ﹤0.01%
2,076
-3,520
-63% -$240K
SLQT icon
2984
SelectQuote
SLQT
$129M
$123K ﹤0.01%
6,087
+3,833
+170% +$79.8K
MMAC
2985
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$123K ﹤0.01%
5,470
+3,467
+173% +$85.6K
BGSF icon
2986
BGSF Inc
BGSF
$60.7M
$122K ﹤0.01%
14,407
+11,459
+389% +$110K
OCFC icon
2987
OceanFirst Financial
OCFC
$1.91B
$122K ﹤0.01%
8,925
+2,094
+31% +$32.9K
PCB icon
2988
PCB Bancorp
PCB
$401M
$122K ﹤0.01%
13,896
+11,259
+427% +$107K
SDOW icon
2989
ProShares UltraPro Short Dow 30
SDOW
$186M
$122K ﹤0.01%
422
-665
-61% -$211K
NBSE
2990
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$122K ﹤0.01%
801
+620
+343% +$101K
GBT
2991
DELISTED
Global Blood Therapeutics, Inc.
GBT
$122K ﹤0.01%
2,213
-13,064
-86% -$830K
SLCT
2992
DELISTED
Select Bancorp, Inc.
SLCT
$122K ﹤0.01%
16,975
+13,639
+409% +$104K
CLPR
2993
Clipper Realty
CLPR
$53.3M
$121K ﹤0.01%
20,024
+15,425
+335% +$104K
CSIQ icon
2994
Canadian Solar
CSIQ
$1.03B
$121K ﹤0.01%
3,454
+3,305
+2,218% +$88.1K
FOLD
2995
DELISTED
Amicus Therapeutics
FOLD
$121K ﹤0.01%
8,562
-18,862
-69% -$275K
IOVA icon
2996
Iovance Biotherapeutics
IOVA
$2.94B
$121K ﹤0.01%
3,675
-19,103
-84% -$586K
KKR icon
2997
KKR & Co
KKR
$103B
$121K ﹤0.01%
+3,524
New +$123K
SMSI icon
2998
Smith Micro Software
SMSI
$15.9M
$121K ﹤0.01%
814
+772
+1,838% +$122K
SPRU icon
2999
Spruce Power Holding Corp
SPRU
$36M
$121K ﹤0.01%
+1,318
New +$110K
UBX
3000
DELISTED
Unity Biotechnology
UBX
$121K ﹤0.01%
3,520
+2,941
+508% +$186K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.